JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $100,000 | -6.5% | 14,800 | +15.6% | 0.00% | 0.0% |
| Q4 2021 | $107,000 | +37.2% | 12,800 | +12.3% | 0.00% | +50.0% |
| Q2 2021 | $78,000 | +3800.0% | 11,400 | +5600.0% | 0.00% | – |
| Q3 2020 | $2,000 | -94.7% | 200 | -95.3% | 0.00% | -100.0% |
| Q4 2019 | $38,000 | +81.0% | 4,300 | +30.6% | 0.00% | 0.0% |
| Q3 2018 | $21,000 | +16.7% | 3,293 | +43.2% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |